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Abstract
Despite years of research, the reprogramming of human somatic cells to pluripotency remains a slow, inefficient process,
and a detailed mechanistic understanding of reprogramming remains elusive. Current models suggest reprogramming to
pluripotency occurs in two-phases: a prolonged stochastic phase followed by a rapid deterministic phase. In this paradigm,
the early stochastic phase is marked by the random and gradual expression of pluripotency genes and is thought to be a
major rate-limiting step in the successful generation of induced Pluripotent Stem Cells (iPSCs). Recent evidence suggests
that the epigenetic landscape of the somatic cell is gradually reset during a period known as the stochastic phase, but it is
known neither how this occurs nor what rate-limiting steps control progress through the stochastic phase. A precise
understanding of gene expression dynamics in the stochastic phase is required in order to answer these questions.
Moreover, a precise model of this complex process will enable the measurement and mechanistic dissection of treatments
that enhance the rate or efficiency of reprogramming to pluripotency. Here we use single-cell transcript profiling, FACS and
mathematical modeling to show that the stochastic phase is an ordered probabilistic process with independent genespecific dynamics. We also show that partially reprogrammed cells infected with OSKM follow two trajectories: a productive
trajectory toward increasingly ESC-like expression profiles or an alternative trajectory leading away from both the fibroblast
and ESC state. These two pathways are distinguished by the coordinated expression of a small group of chromatin modifiers
in the productive trajectory, supporting the notion that chromatin remodeling is essential for successful reprogramming.
These are the first results to show that the stochastic phase of reprogramming in human fibroblasts is an ordered,
probabilistic process with gene-specific dynamics and to provide a precise mathematical framework describing the
dynamics of pluripotency gene expression during reprogramming by OSKM.
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In the past several years, ChIP-seq and RNA-Seq experiments
have revealed ensemble gene expression and epigenetic changes
that occur during reprogramming by OSKM, and have greatly
enhanced our understanding of the process [2,12–15]. These
studies require the use of populations of cells comprised of
heterogeneous mixtures undergoing reprogramming (0.01–0.1%
of which will become iPSC) or stable, partially reprogrammed selfrenewing lines arrested in a partially reprogrammed state, unlikely
to ever become iPSCs without additional manipulation [5–8].
Because these techniques rely on either the ensemble properties of
mixed populations, or upon the analysis of cell lines arrested at
partially reprogrammed states that may not be representative of
normal intermediate steps in a functional reprogramming process,
they have limited ability to reveal the changes that appear to be
essential to successful reprogramming.
Longitudinal single-cell imaging studies provide a powerful
complement to ensemble, population level analyses. Live imaging

Introduction
Methods of reprograming somatic cells to a pluripotent state
(iPSC) have enabled the direct modeling of human disease and
ultimately promise to revolutionize regenerative medicine [1,2].
While iPSCs can be consistently generated through viral infection
with the Yamanaka Factors OCT4, SOX2, KLF4, and c-MYC
(OSKM) [3], infected cells rapidly become heterogeneous with
significant differences in transcriptional and epigenetic profiles, as
well as developmental potential [4–8]. This heterogeneity, the low
efficiency of iPSC generation (0.1–0.01%) and the fact that many
iPSC lines display karyotypic and phenotypic abnormalities [9–11]
has hindered the production of iPSCs that can be used safely and
reliably in a clinical setting. A thorough mechanistic understanding of the reprogramming process is critical to overcoming these
barriers to the clinical use of iPSC.
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studies have identified a number of key morphological and cell
cycle related changes that occur during reprogramming to iPSC
[16,17]. These observations suggest that an ordered set of
phenotypic changes precede acquisition of the fully pluripotent
state [13]. However, these studies are necessarily limited in their
molecular-genetic resolution, and they provide little insight to the
transcriptional changes accompanying key morphological and
developmental transitions in the reprogramming process.
Recently, a single-cell transcriptional analysis of reprogramming
of mouse fibroblasts by OSKM revealed that reprogramming
proceeds in two major phases: an early stochastic phase followed
by a rapid ‘‘hierarchical’’ phase [18]. While the latter phase
appears deterministic and is characterized by the coordinated
expression of pluripotency genes in an ordered fashion, the early
phase exhibits apparently random gene expression patterns that
persist through the majority of the process [18,19]. This
conclusion is further supported by two key pieces of evidence
from other studies: 1) transgenic OSKM activity is required for the
majority of the reprogramming process, indicating that most of
this process is not governed by the concerted action of the
endogenous pluripotency gene regulatory network (GRN)
[16,20,21]; and 2) a mechanistically undescribed period of variable
‘latency’ of cells in the stochastic phase results in significant
temporal variability in the appearance of fully reprogrammed
iPSC colonies [22]. Some insight to pluripotency gene activation
during the stochastic phase was provided by a recent study in
mouse fibroblasts that describes the ‘gradual activation of
pluripotency genes’ between the initial response to OSKM
induction and the activation and stabilization of the pluripotency
GRN [23]. Together, these findings suggest that the stochastic
phase is a major rate-limiting step in the reprogramming process,
but provide little mechanistic insight into the molecular underpinnings of these events. In addition, it has not yet been
determined how these findings translate to the reprogramming
of human cells, which will be required prior to clinical application
of iPSCs.
Several studies have attributed the protracted stochastic phase
to the requirement for extensive chromatin remodeling during
reprogramming [24,25]. These changes involve the complex
coordination of factors to deposit and remove histone modifications and DNA methylation at specific loci to achieve a pluripotent
epigenetic state. The need to reset the epigenetic landscape
appears to delay the coordinated activation of the pluripotency
GRN and is likely to be a major barrier to rapid and efficient
reprogramming. Indeed, it has been shown that OSKM binding in
the early stages of reprogramming is greatly impeded by the
presence of repressive chromatin, and initial binding is largely
restricted to existing open chromatin domains [2,14,15,26,27].
Subsequent remodeling of somatic cell chromatin clearly occurs,
but the order and mechanism of remodeling events during the
stochastic phase is not fully understood. Accurate mapping of gene
expression dynamics during the stochastic phase can provide a
framework for the molecular dissection of these rate-limiting
events in reprogramming.
In this study we perform single-cell transcript analysis of MRC5 human lung fibroblasts undergoing reprogramming by OSKM
and find that cells appear to follow two trajectories: one toward an
ESC-like state (the ‘‘productive’’ trajectory) and the other away
from both ESC and fibroblasts (the ‘‘alternative’’ trajectory). These
trajectories can be differentiated by the concerted consolidation of
expression of a suite of chromatin modifiers in cells entering the
productive trajectory and the down-regulation of these same genes
in cells entering the alternative trajectory. By analyzing the
dynamics of gene expression changes along the productive
PLOS ONE | www.plosone.org

trajectory (toward pluripotency) we demonstrate that changes in
gene expression in the stochastic phase of reprogramming are not
simply gradual and random; rather, genes are activated and
inactivated at specific points during the progression from fibroblast
to iPSC. Coupling single-cell transcript profiling with mathematical modeling we show that the gradual acquisition of pluripotency
gene expression during reprogramming occurs as an ordered,
probabilistic, gene-specific process that shows no signatures of
interdependence between genes. This finding is consistent with the
hypothesis that gene-specific chromatin states in the starting cells
control gene activation dynamics during the reprogramming
process. Our map of reprogramming also provides a robust model
that can be used to dissect the precise mechanisms and chromatin
modifications that limit the rate and efficiency of conversion of
somatic cells to iPSC. This work represents a rigorous single cell
transcript analysis of the reprogramming process in human cells
and lays the foundation for the precise measurement and
mechanistic dissection of this critical rate-limiting step in
reprogramming.

Results
Experimental Design
In this report we combine qualitatively and quantitatively robust
single-cell transcript profiling [28] with FACS to measure the
progression of individual MRC-5 human fetal lung fibroblasts
through the reprogramming process. To make our results as
broadly relevant as possible we used viral delivery of the OSKM
transgene cocktail, the most widespread method applied to human
cell reprogramming [29,30]. At select time points after transduction, cells were dissociated, stained, analyzed and collected by
FACS. FACS markers used in this study include GFP (virus
derived), aSSEA4, aTRA-1-60, and aCDH1 (see Materials and
Methods). These markers were essential and allowed for enrichment of the rare cells exhibiting hallmarks of productive
reprogramming. For example, SSEA4 and TRA-1-60 routinely
provide ,30 and 3,000 fold enrichment, respectively (data not
shown). While very few SSEA4+ cells are likely to become true
iPSCs, they provide a measurement of cells that have begun to exit
the fibroblast in response to OSKM transduction. In contrast,
isolation of TRA-1-60+ cells later in reprogramming (Day 14) is
likely to yield a large number of cells destined to become iPSC. In
fact, .90% of these cells remain TRA-1-60+ after sorting and
subsequent culture and this stability of the TRA-1-60+ phenotype
has been shown to be a major determinant for the potential of cells
to become iPSC [31]. Single cells with defined FACS phenotypes
were collected into cell lysis buffer and subject to single-cell RTqPCR as previously described [28] (Figure 1A and Figure S1).
Throughout the course of this study we isolated and pre-screened
576 cells in total, using 172 cells that passed quality control for our
final analysis (see Materials and Methods and Table S3). This
includes many partially reprogrammed cells, as well as an untransduced set of MRC-5 fibroblasts and H9 human embryonic
stem cells (H9-hESC), which represent the beginning and end
states of the process, respectively (for full dataset see Table S4).
In order to monitor progress toward pluripotency, and away
from the fibroblast state, we assembled a 48-gene qPCR (Table S1)
panel including genes expressed in fibroblasts [17,32,33], a large
number of genes involved in the maintenance of pluripotency
(including various chromatin modifiers) [12,34–36] and genes
previously suggested to be intermediate markers of the reprogramming process [37,38]. For a complete list of qPCR markers
see (Figure 1B and Figure S2). Initial visualization of the full
dataset by unsupervised hierarchical clustering reveals that our
2
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Figure 1. Schematic representation of the pipeline used to isolate and analyze single cells undergoing OSKM-mediated
reprogramming. A) Cells were infected with OSKM (MOI = 5) and cultured for 4, 8 or 14 days prior to harvest. Cells were then singularized and
stained with SSEA4 and TRA-1-60 antibodies and subjected to FACS. SSEA4+/TRA-1-602 (SSEA) and SSEA4+/TRA-1-60+ (TRA-1-60) single cells were
sorted directly into lysis buffer in 96-well plates followed by RT and linear pre-amplification. Amplified cDNA samples were used for Taqman qPCR
analysis of 48 genes on an Applied Biosystems 7900 HT real time machine and data analysis was performed in JMP. B) Table of the 48 gene panel
used for qPCR analysis, categorized as fibroblast-associated, pluripotency-associated, intermediate marker or chromatin modifier gene. C)
Unsupervised hierarchical clustering analysis illustrating the effective isolation of single cells by FACS for SSEA4 and TRA-1-60 surface markers. While
some overlap is observed between the two populations, they are largely transcriptionally separable. GFP+-only and CDH1+ populations have been
excluded for illustrative purposes.
doi:10.1371/journal.pone.0095304.g001

determine the order of gene activation during the reprogramming
process.

FACS sorting strategy, and qPCR marker panel, isolates
statistically separable populations that capture a range of
transcriptional phenotypes between the fibroblast and pluripotent
states (Figure 1C). We then performed a series of statistical
analyses to: 1) describe probable trajectories followed by OSKMinfected cells; 2) measure the progress of cellular transcriptional
profiles toward a pluripotent transcriptional phenotype; and 3)

PLOS ONE | www.plosone.org

Mapping the Trajectory of OSKM-Infected Cells
Throughout Reprogramming
As a first step in visualizing our single cell transcription dataset,
we used principal components analysis (PCA) to assess the
complexity and major sources of variation in gene expression
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characterized by the consolidation of chromatin modifier expression, an increased probability of pluripotency gene expression, a
progressive decrease in the expression of fibroblast markers and
transient expression or repression of predicted intermediate
markers [22,38]. Among the earliest distinctions between the
productive and alternate trajectories (Early vs Alt) is the induction
of chromatin-modifying enzyme expression. While many of these
genes are expressed at low levels in fibroblasts, they are
coordinately up-regulated in the ‘‘Early’’ group, and become
expressed at uniformly high levels in all cells progressing towards
pluripotency. In contrast, cells in the alternate trajectory downregulate or eliminate expression of these genes (Fig. 2G). In
addition, ‘‘Alt’’ cells fail to upregulate the expression of early
pluripotency genes (Figure 2H) and are found at all of the time
points examined, suggesting that these cells are unlikely to be on a
trajectory that ultimately leads to pluripotency. Because ‘‘Alt’’ cells
appear to be following an orthogonal trajectory that may lead to
fates unrelated to ESC (such as transformation or apoptosis
[39,40]) they were excluded from further analysis of the productive
reprogramming trajectory.
Taken together these data indicate that OSKM infected cells
exit the fibroblast state along two distinct trajectories, and that the
upregulation of chromatin modifiers marks a key early step
towards successful reprogramming. The rapid upregulation of
chromatin modification genes is consistent with the need for
extensive chromatin remodeling prior to establishment of the
endogenous pluripotent GRN [2,41,42].

between all cells collected in our study. This analysis reveals that
the first two PCA dimensions account for 33.1% of the observed
variation, where PC1 primarily represents a cell’s distance from
hESC, and PC2 primarily captures distance from fibroblasts
(Figure 2A). In addition, these two axes appear to represent
distinct trajectories followed by cells transduced with OSKM The
first is a roughly linear productive trajectory between the fibroblast
and hESC groups (R2 = 0.60, Figure 2B) and the second is an
orthogonal trajectory leading away from fibroblast but not towards
a pluripotent phenotype (herein referred to as the alternate
trajectory, or ALT). Because the productive and alternate
trajectory are well correlated with the PC1 and PC2 dimensions
respectively (Figure 2C) and capture much of the variation in our
dataset, we developed a metric to analyze our data in a 2dimensional Euclidean space that maps each cell’s distance
(relative similarity) to the centroids of both the Fibroblast and
hESC groups. In addition, we construct a Euclidean diagonal
between Fibroblast and hESC which we term the ‘‘reprogramming progression axis’’. This axis serves as a useful measurement
of a given cell’s progression towards pluripotency and is a metric
used in all subsequent analysis presented here.
It is important to note that our analysis constructs likely
reprogramming trajectories by sampling partially reprogrammed
cells. This approach is common among many efforts to sample
dynamic processes and is particularly ubiquitous in attempts to
dissect the reprogramming process [19,24,39]. We apply the
standard parsimonious assumption that the shortest path defined
by these samples represents the most likely trajectories of the
process. One caveat of this approach is that we cannot exclude the
possibility that progression within the observed state-space is nonlinear, and may be complex and/or cyclical. These possibilities
will need to be ruled out with longitudinal live cell studies beyond
the scope of this work. Another important consequence is that
while cells clearly take time to traverse the trajectory, we do not
expect progress along a trajectory to have a linear relationship
with time. However, progress may be loosely thought of as a
surrogate for time but should not be strictly interpreted as such.
Interestingly, when mapping the FACS-sorted phenotypes onto
our Euclidean similarity graph we noticed that, while SSEA4 and
TRA-1-60 appear in the expected order (SSEA4+ before TRA-160+), the SSEA4+ and SSEA4+/TRA-1-60+ populations exhibit
considerable transcriptional heterogeneity (Figure 2D). SSEA4
positive cells are found in both the productive and alternative
trajectories suggesting that, while SSEA4 may be a reliable marker
of exit from the fibroblast state, it does not necessarily indicate that
cells have moved toward a pluripotent transcriptional phenotype.
Even more pronounced is the diversity of TRA-1-60 positive cells.
The transcriptional phenotype of these cells extends from a nearly
fibroblast-like profile, to a nearly ESC-like profile. The extremely
high degree of transcriptional heterogeneity we observe, even
within well-defined and widely utilized FACS profiles, underscores
the utility of single cell analysis to dissect fine differences in gene
expression between partially reprogrammed cells.
With the phenotypic diversity of commonly utilized cell surface
markers in mind, we utilized a Self-Organizing Map (SOM) to
identify separable groups along the two previously described
reprogramming trajectories in both PCA and Euclidean space
(Figure 2E and F, respectively). Four of these groups (Fib, Early,
Late and Pluri) lie along the productive trajectory from Fibroblast
to ESC and the fifth encompasses cells in the alternate trajectory.
It is important to note that while these groups can be statistically
distinguished from one another, we do not believe these represent
discrete stages in the reprogramming process. Further inspection
reveals that progression along the productive trajectory is
PLOS ONE | www.plosone.org

Mapping Coarse Changes in Gene Expression along the
Productive Trajectory
In order to provide a rough benchmark for other literature
examining transcriptional changes in ensemble samples of partially
reprogramed cells, we identified quantitative expression differences between SOM groups along the productive trajectory (Figure 3).
It is clear from this data that specific changes in gene expression
occur along different portions of the trajectory, which suggests an
underlying order to the gradual acquisition of pluripotency gene
expression during the reprogramming process. However, closer
analysis reveals that there does not appear to be tight covariance
between genes activated along the progression toward pluripotency. Representative bubble plots illustrating transcript presence and
absence (Figure 3 and Figure S2) show that genes being activated
during reprogramming exhibit a period of heterogeneity in
transcript detection prior to being detected in all cells approaching
pluripotency. Quantitative analysis of gene expression levels also
supports this finding (Figure 3, Figure S3). These plots depict gene
expression levels on the y-axis, overlain with a distribution graph
showing the range of expression values within the population. A
unimodal distribution indicates uniform expression around a mean
within the population, whereas a bimodal distribution demonstrates a transcriptionally heterogeneous population (e.g. high/low)
for the gene in question. Nearly all the genes in our study exhibit
this bimodal behavior at some point along the reprogramming
trajectory, before achieving a unimodal distribution as they
approach the fully reprogrammed state, however the point of
bimodality varies in a gene-specific manner. These findings
demonstrate that the activation or inactivation of gene expression
during reprogramming proceeds through a probabilistic intermediate step, resulting in transcriptionally heterogeneous cell
populations, and that the timing of this transition occurs with
gene specific dynamics.
In order to scan for potential differences in reprogramming
gene expression dynamics between species (mouse and human) we
processed our data so that it would be roughly comparable to that
4
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Figure 2. Mapping the trajectories of OSKM- infected cells. A) Principle Components Analysis (PCA) shows the two trajectories followed by
OSKM-infected cells. One productive trajectory leading away from the starting fibroblast population (purple oval) and towards the hESC group (teal
oval) and a second, orthogonal trajectory leading away from both fibroblast and hESC, denoted as the ‘‘alternate trajectory’’. B) Regression analysis
showing the linear nature of the productive trajectory. C) Correlation analysis between PC1 and the productive trajectory (C, top panel) and PC2 and
the perpendicular distance to the productive trajectory. D) Mapping of cell types onto a Euclidean distance graph shows the broad range of
transcriptional phenotypes observed for SSEA4+ (blue oval) and TRA-1-60+ (pink oval) FACS-sorted cells. Also included are untransfected MRC-5
fibroblasts (purple oval) and pluripotent H9 hESC cells (teal oval). Self-Organizing Map (SOM) analysis identifies transcriptionally separable groups
within our dataset in PCA (E) and Euclidean (F) space. This includes 4 groups along the productive trajectory (Fib, Early, Late and Pluri) as well as one
group comprised of cells in the alternate trajectory (Alt). G) Violin plots comparing expression of chromatin modifier genes between the Alt (red), Fib
(green) and Early (blue) groups. Gene expression levels are plotted on the y axis, with the width of the graph representing the prevalence of cells at a
given expression level. H) Bar graph illustration differences in pluripotency gene expression between the Alt and Early groups.
doi:10.1371/journal.pone.0095304.g002

datasets appear to exhibit similar dynamics in the stochastic phase.
That is, early mouse genes change expression early in the human
trajectory, while late genes change later in the trajectory.
However, despite the coarse limits of resolution in this comparison,
several genes, including NANOG, LIN28A, POU5F1 and
STAT3, appear to change at different stages of the reprogramming process in these two species. These disparities, while
requiring more direct comparison and detailed confirmation, are

generated by Polo et al [23]. As in the present study, Polo and
coworkers used FACS to isolate and measure the transcriptional
profiles of a large number of partially reprogrammed mouse
fibroblasts and clustered genes based on their expression
dynamics. We compared these clusters to the dynamics of the
human orthologs [12,34] represented in our dataset (Figure S4).
While high-resolution comparison was not possible with the
publically available mouse data, most genes shared between

PLOS ONE | www.plosone.org
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Figure 3. (Middle panel) Tukey-Kramer test results showing significant increases or decreases in gene expression between the groups identified in
the PC-SOM analysis (p.0.05). Genes are ranked in order of significance from highest to lowest. Violin and bubble plots (above and below) show

PLOS ONE | www.plosone.org
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qualitative and quantitative changes (respectively) in per-cell gene expression for the genes with the greatest change between groups. Top panel
shows genes whose level and probability of expression undergo an ‘‘activating’’ effect during reprogramming, while genes with decreased
probability of expression during reprogramming are labeled ‘‘inactivating’’ and shown in the bottom panel.
doi:10.1371/journal.pone.0095304.g003

so only marginally (Figure 4C). In addition, most genes that do not
reject the uniform model exhibit little or no change over the course
of reprogramming or have noisy expression profiles. Both of these
observations suggest that most gene expression changes occurring
during the stochastic phase are not simply gradual acquisition of
an ESC-like expression frequency, rather they turn on and off at
specific points in the process.
To further assess the confidence with which random change
(uniform probability distribution) in gene expression during the
stochastic phase can be rejected by our models (Gaussian
probability distribution) is to compare the explanatory power of
each model, as adjusted for the additional parameters required in
each more progressively complex scenario. Figure 4D shows that
while one normal distribution significantly improves AIC (lower is
better), two normal (or even three normal - data not shown) do not
add much explanatory power. One exception is for genes that
exhibit transient expression changes, the fits for which are shown
in Figure S6. For this reason, we suggest that gene expression
dynamics during the stochastic phase are best described as events
occurring at specific points in the process, where most gene’s
expression dynamics are well described by a single normal
probability distribution centered at the point of maximal rate of
change. Genes that change at very specific points in the process
have very tight probability distributions, while genes with less
precise dynamics display broader probability distributions (approaching the uniform distribution of our null model).
In order to compare dynamics between genes, we modeled each
gene in our study using single Gaussian probability distributions as
described above. All model fits are illustrated in the Figures S5.
One example fit is illustrated for CDH1 in Figure 5A. In this figure
the black dots represent measured expression frequencies of
CDH1 in sliding windows along the inferred reprograming
trajectory. The red curve shows gene expression dynamics
modeled as a Gaussian probability distribution fit to the
experimental data and the blue line illustrates expression
frequencies predicted by that probability curve.
When the dynamics of several genes are compared in one graph
(Figure 5B–E) it is readily apparent that: 1) genes are activated or
inactivated at different points during the reprogramming process; 2) genes have
specific stringencies in their activation dynamics (some genes change at fairly
specific stages, while others change over almost the entire course of the process);
and 3) there is considerable overlap in the expression probabilities of individual
genes. Most genes are activated or repressed with diffuse dynamics,
while several (NANOG, CDH1, ZFP42, ZIC3 and OTX2) change
at more specific stages of the reprogramming process. The diffuse
dynamics and broad windows of activation observed for most
pluripotency markers is consistent with the longitudinal observation that the expression of the surface antigens SSEA4 and TRA1-60 in iPSC colonies are not strongly predictive of successful
reprogramming events [20,37]. Taken together, this data strongly
supports the hypothesis that rather than being a strictly ordered or
strictly random process, the stochastic phase of reprogramming is
an ordered probabilistic process. Seen in this light, prior ordered and
random models can be coherently united [43][44][19].

consistent with distinct differences between regulation of the
pluripotent state in mouse and human cells as well as probable
differences in the starting chromatin state of loci in mouse and
human fibroblasts.

Reprogramming is a Loosely Ordered Probabilistic
Process Effectively Modeled by Gaussian Distributions
Our observation that distinct transcriptional differences exist
between PC-SOM clusters indicates that gene expression changes
during the stochastic phase of reprogramming appears to occur in
an ordered fashion. However, the coarse grained nature of this
differential analysis between statistically identifiable, but not
necessarily biologically relevant groups, provides little insight to
the exact nature of the order of gene expression dynamics during
the stochastic phase. In particular, we wanted to address two
specific questions: 1) Is the acquisition of pluripotency gene
expression random and gradual, with all genes approaching a
pluripotent profile at a uniform rate over the course of the
process?; and 2) Is there sub-structure within the patterns of gene
activation that would suggest the activation of modules within the
pluripotency GRN? We addressed these questions by differentiating between null and alternative hypotheses (in the form of
distribution models) predicting gene expression frequencies along
the reprogramming trajectory from MRC-5 to H9-ESC and
comparing these to what we observe in our experiments.
In order to formally address the first question we modeled
random gradual change in gene expression by assigning each
fibroblast and pluripotency marker a uniform rate (probability) of
change along the trajectory from MRC-5 to H9-ESC that would
result in predicted gene expression frequencies that match the
observed frequencies at the start (MRC-5) and end (H9-ESC) of
the process [23]. In contrast, our alternative hypothesis was that
genes change expression at specific stages of the process; in other
words, gene expression during the stochastic phase is ordered. This
alternative scenario was modeled by fitting Gaussian probability
distributions to each gene such that the probability distribution
was centered at the point of greatest change in gene expression
frequency along the reprogramming trajectory. In order to model
the behavior of transient genes, and to help calibrate differences
between goodness of fit between models, we also built more
complex models with two probability distributions, which allowed
us to model genes that change expression at two points in the
process. Changes in gene expression frequency predicted by our
null model are linear, while the alternative model with one
probability distribution predicts sigmoidal changes and the two
distribution model allows for more complex dynamics of change in
gene expression frequency, such as transient activation or
inactivation. The goodness of fit of each model to our observed
data was then measured for each gene in both PCA and Euclidean
space using an F-test statistic. Because goodness of fit typically
scales with the number of parameters in a model, the Gaussian
models were penalized for added parameters using a corrected
Akaike Information Criterion (AIC, see Materials and Methods).
The results of these tests can be found in (Figure 4A–D and Table
S2).
As demonstrated in Figure 4B, the vast majority of genes reject
the null hypothesis (F-statistic.F-Critical) in favor of a Gaussian
model. Note that many genes that reject the null hypothesis do so
very strongly, while the few genes that better fit linear dynamics do
PLOS ONE | www.plosone.org
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Figure 4. Rejection of a uniform model and justification of modeling using Gaussian distributions. (A) Predicted outcomes of gene
expression probabilities associated with uniform (left panel) or Gaussian (right panel). Uniform and Gaussian probability distributions (dashed line)

PLOS ONE | www.plosone.org
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give rise to cumulative probabilities (solid line) that describe the population of cells at a given point in time. A Uniform probability results in the
gradual activation/inactivation of a gene throughout the process, while Gaussian distributions suggest a bias in expression change towards a
particular point in the process. (B) Pie charts showing the relative number of genes that accept or reject the Uniform (left panel) or Gaussian model
(right panel) as determined using an F-statistic test. The strength with which these genes accept or reject each model is shown in (C). (D) Comparison
of AICC value for all genes between the Uniform model and a Gaussian model using one or two normal distributions. While considerable
improvement is observed for the Gaussian vs Uniform model, the addition of a second normal distribution does not dramatically improve model fit.
doi:10.1371/journal.pone.0095304.g004

in frequency of pluripotency markers as cells approach an ESClike transcriptional profile. Our alternative hypothesis is that some
pluripotency genes may be co-regulated (or cross-regulate) during
the stochastic phase and would thus display higher than
background levels of co-expression (as measured by correlation).
To test these hypotheses we used the probability profiles of each
gene to generate a simulated data set in which gene expression is
determined only by the probability profile of each gene, with no
dependencies between genes. The resulting dataset accurately
recapitulates the individual dynamics of each gene in our dataset,
and provides pairwise correlation values that are solely dependent
upon the convergence of all pluripotency markers on uniform
expression in ESC. We then compared pairwise correlations
between genes in this background data set with the real
correlations observed in our single-cell transcript data (Figure 6).
Interestingly, the only correlations we find rise above background expectations occur between a set of chromatin regulators
that distinguish between entry into the productive trajectory and
entry into the alternative trajectory (Figure 6). This coordinated
activity is likely the result of activation of the c-MYC GRN, which
is known to be activated upon OSKM induction, and is largely
limited to genes with a permissive chromatin state in fibroblasts as

Changes in Pluripotency Gene Expression during the
Stochastic Phase do not show Hallmarks of Activation of
the Pluripotency Gene Regulatory Network
Having observed ordered dynamics in the stochastic phase, we
sought to determine if there was any indication that this order
might arise from the partial activation of the endogenous
pluripotency GRN. Current models suggest that partially reprogrammed cells enter a late, rapid deterministic phase that is
controlled by activation of the endogenous pluripotency GRN and
may be marked (in mouse cells) by the activation of the
endogenous Sox2 locus [20,46]. Alternatively, order could emerge
gradually or piecemeal during the stochastic phase. A hallmark of
concerted gene regulation as exerted by a GRN, is strong
correlation (or anti-correlation) between gene expression patterns
[18,19,23]. Our model provides a powerful way to detect
correlated gene expression that lies above the background
correlations inherent during reprogramming (i.e. pluripotency
markers all become expressed in fully reprogrammed cells). In this
case, our null hypothesis is that during the stochastic phase there is
no dependency between genes and that all correlation between
gene expression in individual cells results simply from the increase

Figure 5. (A) Goodness of fit of a Gaussian model using activation of the CDH1 gene as an example. Gaussian distributions are represented as box
and whisker plots for activating (B) and inactivating (C) genes. Yellow boxes and blue whiskers represent the 50% and 95% confidence intervals of the
normal curve respectively, with the means shown as black lines. Cumulative distributions derived from the Gaussian model are overlaid for genes that
are activated (D) or inactivated (E) during the course of reprogramming.
doi:10.1371/journal.pone.0095304.g005
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Figure 6. Cells undergoing reprogramming do not show hallmarks of activation of the pluripotency GRN. Heat map shows
background-corrected Pearson’s correlation coefficients for all genes in our dataset, excluding NR0B1 and REST (due low detection frequency).
Significant correlations (red dots) are primarily observed for chromatin genes, while the majority of pluripotency genes show no significant
correlations (blue dotes). A small group of pluripotency genes with significant correlations exhibit an open chromatin state in the starting cell type
indicated by H3K4me3 promoter methylation and DNase hypersensitivity (Inset).
doi:10.1371/journal.pone.0095304.g006

local properties of each gene, rather than the sequential activation of
precursors in the GRN. Of course, the numbers of genes we
analyze in our study somewhat limits the power of this analysis,
and a more comprehensive single-cell study measuring many more
genes might uncover obligate relationships between genes that are
not apparent in our core pluripotency GRN gene set.

is the case for many chromatin modifier genes [45,46] (Figure 6,
inset). In contrast, none of the correlations between members of
the pluripotency GRN rise above background expectations,
despite their overall increase in expression frequency as cells
approach an ESC-like expression profile. We therefore accept the
null hypothesis: that despite the ordered activation of genes in the
pluripotency GRN during the reprogramming process, there is no
evidence for gradual or modular activation of the pluripotency
GRN during the stochastic phase of reprogramming. An
important corollary that follows from this result is that the dynamics
of gene activation during the stochastic phase appear to depend only upon the

PLOS ONE | www.plosone.org

Discussion
In this study we present a rigorous single cell analysis of
reprogramming in human cells and show that the stochastic phase
of reprogramming of human fibroblasts by OSKM is an ordered
10
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probabilistic process which can be simply modeled using
independent Gaussian distributions. An advantage of our
approach lies in the fact that it makes no a priori assumptions
about the progression of cells toward pluripotency, based on time
or surface marker expression, both of which are poor indicators of
reprogramming progress. In addition, the simplicity of our model
and its exceptional fit to our observed expression dynamics
provide a tractable framework for further dissecting the ratelimiting aspects of reprogramming. The results of this work also
unify existing ordered and random models of the stochastic phase
of reprogramming [16–18,21,22,37] and are consistent with
observations from both population level and single cell studies of
gene expression changes during reprogramming [37,38,43]. The
ordered nature of the stochastic phase is readily apparent in the
distinct, gene-specific expression dynamics we observe during
reprogramming, while the probabilistic nature of the process is
evident in broad gene-specific expression dynamics over large
portions of the reprogramming trajectory (Figure 5 and Figure 7),
and the apparently independent control of gene expression
dynamics during the stochastic phase (Figure 6). These findings
are consistent with a recent study by Tanabe et al. [31] that
suggests the TRA-1-60+ phenotype is unstable and transcriptionally heterogeneous and that stabilization of the TRA-1-60+
population is a critical rate limiting step in reprogramming. Note
we suggest retaining the term ‘‘stochastic’’ for this phase of the
reprogramming process, in that stochastic can be used to describe
ordered probabilistic events, and does not necessarily imply
complete randomness. The use of the term stochastic is especially
appropriate given the independence of activation dynamics of key
genes in the core pluripotency GRN.
One consequence of the independent activation of genes during
reprogramming is that an extremely wide variety of cell states are
present during the reprogramming process, which gives the overt
appearance of disorder. Thus, while any given partially reprogrammed cell’s gene expression pattern may appear to be random,
the probabilities of expression of individual genes are clearly
biased towards specific points along the reprogramming trajectory.
One implication of these findings is that any single marker is
unlikely to be effective at determining the extent to which a given
cell has been reprogrammed [37,47].
We note that variations in the cell cycle could contribute to the
transcriptional heterogeneity of a subset of genes in our dataset.
However recent studies in hESC have shown that the transcription
of genes associated with pluripotency does not fluctuate during the
cell cycle [48], suggesting that cell cycle status is unlikely to have a
major impact on our analysis of the activation of the pluripotency
GRN. In addition, the persistence of cyclin transcripts throughout
the cell cycle and their considerable post-transcriptional regulation
in ESC’s [49], precludes strong inference of cell cycle status from
transcriptional measurement of a single cell-cycle regulator.
Another possible source of transcriptional heterogeneity between partially reprogrammed cells in our cultures could be the
delivery of O, S, K, and M on individual vectors (as is standard in
widely utilized human reprogramming protocols). However the
broad agreement of expression dynamics over the course of
reprogramming between our results using individual viral delivery,
and those reported by Polo et al using an inducible, polycistronic
construct in a clonal cell line, suggests that viral heterogeneity does
not fundamentally affect the order of gene expression dynamics, or
the shape of the trajectory of cells undergoing the reprogramming
process. Furthermore, the initial description of the highly
heterogeneous nature of the stochastic phase by Buganim et al
was also derived from data using clonal cells expressing OSKM
from an inducible polycistronic OSKM construct. Thus, the
PLOS ONE | www.plosone.org

stochastic nature of this phase does not appear to be a direct
consequence of OSKM heterogeneity. However, these results do
not rule out the possibility that each of the OSKM factors have
distinct roles in various stages of the reprogramming process, nor
that heterogeneity in OSKM content will be observed across the
partially reprogrammed population of cells. Indeed, understanding
the role of each factor in the reprogramming process and the
critical window for the action of each represents an important goal
of future work.
A likely explanation for the apparent lack of deterministic
behavior during the stochastic phase may be the existence of as yet
unidentified, gene-specific factors that restrict the rate of
transcription activation by OSKM. One compelling candidate
for these factors is the local chromatin architecture of the
pluripotency genes in the starting somatic cell type. Indeed,
epigenetic remodeling was implicated as a major rate limiting step
in even the earliest days of somatic cell reprogramming using
nuclear transfer [24,25] and is almost certainly one of the most
important probabilistic events limiting the rate and efficiency of
reprogramming. Many reports have experimentally validated this
hypothesis by demonstrating that global chromatin reorganization
is critical for successful reprogramming [2,14,15,27]. Because
many of the required changes in chromatin state appear to occur
in a slow and probabilistic fashion [50–52] it is likely that these
changes limit the rate at which exogenous OSKM can activate the
endogenous pluripotency GRN thus limiting the efficiency and
speed of reprogramming and endowing the majority of the process
with stochastic dynamics.
Our finding, that enhanced expression of chromatin modifiers is
a hallmark of entry into productive reprogramming complements
several studies demonstrating that successful reprogramming
requires the gradual erosion of epigenetic barriers to activation
of the pluripotency GRN by OSKM [2,26,27,40,53]. This event is
likely governed by the activity of c-MYC, which together with
KLF4, acts early in reprogramming to activate loci with permissive
chromatin states, including many chromatin modifier loci in
fibroblasts [14,26]. In addition, many treatments known to enable
chromatin remodeling have been shown to enhance the rate and/
or efficiency of the reprogramming process [53–56], while,
conversely, knocking down factors required for such epigenetic
changes can inhibit or prevent successful reprogramming
[53,54,56–59]. However, with the exception of some very early
events [14,26] the order and precise identity of chromatin
modifications required for successful reprogramming is not yet
well known. By precisely describing and modeling gene expression
dynamics during the stochastic phase the present study provides a
quantitative framework for dissecting these key rate limiting steps
and will enable the mechanistic dissection of interventions known
to accelerate or enhance the efficiency of the reprogramming
process.

Materials and Methods
Production of Retrovirus
Retroviral vectors (pMIG) containing OCT4, SOX2, KLF4, cMYC (OSKM) along with helper plasmids (VSV-G and Gag-pol)
were obtained from I.H.Park (Yale University, New Haven, CT).
To generate viral particles, individual retroviral vectors were cotransfected with VSV-G and Gag-pol into 293T cells seeded at
26106 cells per 10-cm2 using FuGENE 6 transfection reagent
(Roche Applied Science). After 72-hour induction, supernatants
were collected, filtered through 0.45 mm filter and concentrated
using Vivaspin 300,000 MWCO PES filter columns (Sartorius).
Viral titer was determined using FACS analysis for GFP
11
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Figure 7. Combined models describing the trajectories and transcriptional phenotypes observed during somatic cell
reprogramming. (Top panel) Two trajectories are observed for cells undergoing reprogramming by OSKM, a productive trajectory leading
towards pluripotency and an alternate trajectory away from fibroblast but not towards a hESC phenotype. The productive trajectory is characterized
by the expression of the surface markers SSEA4 early and TRA-1-60 late in the process, and in general, involves the down-regulation of fibroblast and
cell cycle-associated genes and simultaneous up-regulation of chromatin modifier and pluripotency genes. Putting our results in the context of the
current literature, we observe an early wave of gene induction involving chromatin modifying enzymes and other loci with an open chromatin state
that is likely the result of cMYC and KLF4 activity at these promoters. This initial wave is followed by a period of independent probabilistic gene
expression, which we have model using a series independent Gaussian distributions. This probabilistic phase of pluripotency gene activation will
eventually lead to an as yet unknown event that allows transition into the deterministic phase and the subsequent acquisition of pluripotency.
doi:10.1371/journal.pone.0095304.g007

expression (encoded in the pMIG vector). An MOI of 5 was used
for all experiments.

(Gibco), 5 mM b-mercaptoethanol (Gibco), and 2 ng/mL b-FGF)
and passaged using standard methods.

Cell Culture and Fibroblast Reprogramming

Antibody Staining and FACS Sorting of Reprogramming
Cells

MRC-5 human fetal lung fibroblasts were obtained from I.H.
Park (Yale University, New haven, CT). Briefly, MRC-5 cells were
expanded in human fibroblast (hFib) media (DMEM (Gibco), 10%
FBS (Milipore), 1% L-glutamine (Gibco) and 1X Penn-Strep
(Gibco). One day prior to infection, 16105 MRC-5 fibroblasts
were seeded into one well of a 6-well dish containing hFib media.
The next day, cells were incubated in RI media (MEM alpha
(Mediatech) and 10% FBS (Millipore)) containing 5 ug/mL
protamine sulfate (Sigma) and OSKM virions for 24 hrs followed
by replacement with fresh RI media. Cells were cultured for
72 hrs post-infection and passaged to two 10 cm2 dishes preseeded with 7.56105 inactivated feeders in hESC media supplemented with 10 mM Y-27632 (Calbiochem). After passaging, fresh
hESC media was added daily until the end of the experiment. H9
human embryonic stem cells (WiCell) were maintained in hESC
media (DMEM F-12 (Gibco), 20% Knockout-Serum Replacement
(Gibco), 1% L-Glutamine (Gibco), 1% Non-Essential Amino Acids
PLOS ONE | www.plosone.org

Reprogramming MRC-5 fibroblast cells were harvested with
1 mL Accumax (Millipore) per well (6-well dish) for 15 minutes at
37uC. Cells were pelleted, washed with PBS (Gibco) and wash
buffer (2% FBS in HBSS (Invitrogen)), and resuspended in wash
buffer. Cells were then stained using antibodies for SSEA4
(Biolegend, Cat# 330405) TRA-1-60 (Biolegend, Cat# 330605),
washed 3 times and resuspended in FACS buffer (1% FBS in PBS).
For FACS, cells were live/dead stained and gated on GFP and
appropriate surface markers as indicated and single cells sorted
into 96 well PCR plates. All FACS was performed using a BD
Bioscience FACS Aria II.

Quality Control and Single Cell qRT-PCR
Single cell qRT-PCR was performed as previously described
[28]. Briefly, single cells were lysed and denatured by incubating at
70uC for 10 minutes and then cooled to 4uC. Cells were then
12
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range and directly counting the number of cells expressing each
gene. Models were generated to then predict the percentage
expressing at any trajectory location. ‘Uniform’ models were
generated by assigning a ‘Baseline’ value at the start of the
trajectory ( = 0), and fixing a slope such that a straight line passed
from the ‘Baseline’ to the value at the end of the trajectory ( = 1).
‘Normal’ models were then fit to this data using the ‘optim’
function in R, attempting to minimize the mean squared error,
using the constraint, StdDev ƒ 3=16 and the following form:

reverse transcribed and pre-amplified using gene specific primers
(0.25X pooled TaqMan assays) and analyzed by qPCR. qPCR
was performed using TaqMan chemistry in 384 well plates on an
ABI 7900 HT Fast Real-Time system. Average cycle threshold
(Ct) values obtained from qPCR reactions were normalized to
GAPDH (DCt), and inverted by taking the (40– DCt) value. To
reduce technical error and ensure robust sample quality, all cells
with a GAPDH Ct value of 25 or greater were excluded from
further analysis. TaqMan assays for endogenous OCT4, SOX2,
KLF4 and c-MYC were directed against the 39-UTR region of the
transcript, which is distinct from the synthetic UTRs incorporated
in the viral OSKM transgenes, conferring their specificity to the
endogenous transcripts.

Xd
dNormal(t) ~ Baselinez i~1 Scalei  NormalCDF
(t,Meani , StdDevi )

Marker Panel Selection
Genes selected for inclusion in our 48 marker panel were chosen
based on several criteria. For pluripotency and chromatin modifier
genes we selected those whose role in the establishment or
maintenance of the pluripotent state was well documented and
experimentally validated. This decision was further informed using
the dataset of Dowell et. al. [60] which assigns a self-renewal score
to genes based on their integration in the pluripotency gene
regulatory network (as determined by direct binding of O, S, K
and/or M) as well as their degree of co-expression with wellestablished pluripotency genes. Fibroblast genes were selected
based on their expression in fibroblasts and absence from hESCs
as determined in [32,61].

In order to verify model quality and compare fitting between
different models, AICc was calculated and a bootstrapping test was
performed. AICc was calculated by:
AICc ~ n ln MSEz2k z

2k(kz1)
n{k{1’

where n is the effective number of sample points present in the
original data, k is the number of free model parameters, and MSE
is the mean squared error from the model prediction to the
training data. Bootstrapping was performed by repeatedly
simulating the training data but using only n bins and randomly
resampling a fixed number of cells from each bin’s range. The
error between the model prediction and the resampled data was
compared to the expected error using an F-test to predict if the
error induced by lack-of-fit exceeded the pure error of the data by
a significant level, and this was tracked as a percentage of all tests
done against the model.

Data Analysis
Distance was determined by reducing gene expression to
0(undetected) and 1(detected, Ct ,40) and calculating the average
Euclidean distance for each cell to the FIB and PLURI groups,
ignoring self-comparisons. Similarity was computed for each group
distance by taking the ratio of the distance between FIB and
PLURI minus each cell’s distance to the group in question, over
the distance between FIB and PLURI minus the average distance
of that group to itself. The average of the similarity to PLURI and
the complement of the similarity to FIB was taken as an estimate of
the progression of each cell along the PLURI trajectory. Distance
off of the trajectory was taken as the Euclidean distance from the
FIB and PLURI similarities to the trajectory value.
PCA-based SOM analysis was performed in JMP, Version 10 (a
SAS product) [62] using a 5-by-1 matrix and visualizing on a
biplot (PC1 vs PC2). Cells within the ‘‘Alt’’ group were considered
to be outliers (as described above) and were excluded from
subsequent analysis, unless otherwise indicated. Hierarchical
clustering was also performed in JMP, using Ward’s method with
no standardization, on (40-DCT) values. Coverage ellipses on the
Euclidian distance graphs represent 90% coverage of the data
points from the group indicated. For correlation analysis Pearson’s
correlation coefficients within a defined SOM grouping were taken
for the entire 48648 matrix of genes analyzed in this study.
Network graphs were constructed in Cytoscape using a forcedirected layout derived from the top 100 Pearson correlations
between all of the cells, excluding outliers, in our analysis (n = 117).

Correlation Analysis
First, simulated populations of an equal size were generated by
sampling a set of points along the reprogramming progression axis
such that they matched the distribution of values in the original
dataset. For each sampling point, representative of a single
simulated cell, each gene was set to detected or undetected
independently, using the frequency curves generated from our
Gaussian model. Pearson correlation coefficients were then
computed for this reference population, and averaged over
repeated runs (n = 1000000). Differences in correlation between
this background dataset and those calculated for our observed data
were then tested for significance using the ‘r.test’ function of the R
package ‘psych’.
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